| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | Director
2 companies
Brady Todd C serves as a President and CEO at ALDX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 11 buys and 2 sells. Those positions are worth an estimated $2.9M at current prices.
Historically, Brady Todd C's trades have earned a below-average insider score of 30/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -34.0%.
The biggest single holding is ALDX (~$2.9M) as President and CEO. Net of sales, the recent Form 4 record there shows accumulation of 191,363 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 250,000 | $1.67 | $418,450.00 | +17.0% | -19.9% | - | |
| Mar 12, 2024 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Sell | 183,238 | $3.17 | $580,759.68 | -11.1% | +28.8% | +132.3% | |
| Jun 23, 2022 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 17,700 | $3.36 | $59,546.34 | +1.5% | +61.6% | +98.1% | |
| Dec 16, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 20,000 | $5.10 | $101,908.00 | +3.2% | - | - | |
| Sep 30, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 8,710 | $5.68 | $49,483.25 | +1.4% | - | - | |
| Sep 23, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 8,680 | $5.81 | $50,432.54 | +1.4% | - | - | |
| Sep 18, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 14,288 | $5.91 | $84,464.94 | +2.4% | - | - | |
| Sep 16, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 13,000 | $5.85 | $75,990.00 | +2.2% | - | - | |
| Sep 10, 2019 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 20,000 | $5.14 | $102,824.00 | +3.6% | - | - | |
| Feb 17, 2017 | ALDX Aldeyra Therapeutics, Inc. | President and CEO | Buy | 22,223 | $4.50 | $100,003.50 | +52.7% | - | - |